PHENOXYTRIAZOLE

European patent · EP3538516 · In force

Register entry

Publication number
EP3538516
Application number
EP17797302
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 6, 2017
Published
Sep 18, 2019
Granted
Jun 16, 2021
Protection ends at the latest
Nov 5, 2037
Next annual fee due
Nov 30, 2026
IPC classes
C07D 401/14 (2006.01)
C07D 413/14 (2006.01)
C07D 403/14 (2006.01)
C07D 417/14 (2006.01)
A61K 31/433 (2006.01)
A61K 31/431 (2006.01)
A61K 31/4245 (2006.01)
A61K 31/435 (2006.01)
A61K 31/44 (2006.01)
A61K 31/497 (2006.01)
A61P 25/00 (2006.01)
Priority
EP 16197660 08.11.2016
PCT application
PCT/EP2017/078260 06.11.2017
PCT publication
WO2018/087018 17.05.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  2. Dec 1, 2024

    Change

    Published in Swissreg on 01.12.2024

  3. Dec 1, 2023

    Change

    Published in Swissreg on 01.12.2023

  4. Dec 1, 2022

    Change

    Published in Swissreg on 01.12.2022

  5. Apr 27, 2022

    Change

    Published in Swissreg on 27.04.2022

  6. Jun 16, 2021

    Granted

    Published in Swissreg on 16.06.2021

Parties

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.